Agree, Bejamin, when I was making the list of drugs in the pipeline and looking at SOX's list of catalysts for the new stickie note, I just thought to myself how crazy it is for the shares to be trading at this level. 201 million market cap for 4 drugs in clinical trials? Nuts. Meanwhile AXON, just starting to develop a drug they bought for 5 million from a big pharma, because the drug FAILED and was shelved -- that has a market cap of 1.2 Billion. Unbelievable.